Iterum Therapeutics plc (ITRMF) Other Non-Current Assets (2017 - 2025)

Iterum Therapeutics has reported Other Non-Current Assets for 9 years, with the latest figure at $29000.0 in Q3 2025.

• On a quarterly basis, Other Non-Current Assets fell 14.71% year-over-year to $29000.0 in Q3 2025; TTM through Sep 2025 was $29000.0, a 14.71% decrease from a year earlier, with the FY2024 full-year figure at $34000.0, down 94.12% from the prior year.
• Other Non-Current Assets was $29000.0 for Q3 2025 at Iterum Therapeutics, down from $34000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $10.5 million in Q1 2021, with the low at $29000.0 in Q3 2025.
• Average Other Non-Current Assets over 5 years is $2.8 million, with a median of $2.4 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets plunged 94.97% in 2024, then declined 14.71% in 2025.
• Over 5 years, Other Non-Current Assets stood at $4.7 million in 2021, then tumbled by 44.83% to $2.6 million in 2022, then sank by 77.48% to $578000.0 in 2023, then slumped by 94.12% to $34000.0 in 2024, then slipped by 14.71% to $29000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $29000.0 (Q3 2025), $34000.0 (Q2 2025), and $34000.0 (Q1 2025), per Business Quant data.